ADVOCATE. CONNECT. INNOVATE.

Bulletin, Institute

NEW COURSE on UNDERSTANDING DRUG PRICING

CLSI is offering a new professional development seminar on February 28 aimed at helping participants understand the complex decisions that guide drug pricing decisions. Taught by Biotech Primer, “Understanding Drug Pricing” will provide invaluable information to those in government, finance, law, insurance and human resources who are seeking to gain a better grasp on how pricing determinations are made.

The intensive one-day course covers:

  • post-approval safety surveillance, drug pricing, drug formularies, and how formularies differ from one insurer to the next
  • how evidence-based medicine can help to inform medication use policy, guidelines, and formulary decisions.
  • the various pharmacoeconomics concepts that guide pricing decisions
  • a description of pricing and marketing strategies used by drug manufacturers, with consideration of a drug’s product lifecycle, direct-to-consumer advertising, and discounts to various purchasers such as government and 340b entities

For more information, click here or contact Stacey Franklin of Biotech Primer as franklin@biotechprimer.com.